A Mijch - JoVE Visualize

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

International Journal of STD & AIDS|December 18, 2003

Randomized trial of an adherence programme for clients with HIVC K Fairley, R Levy, C R Rayner, et al.

AIDS (London, England)|August 16, 2001

Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugsA L Dunne, F M Mitchell, S K Coberly, et al.

HIV Medicine|January 31, 2009

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.

AIDS (London, England)|April 1, 1997

Fertility and reproductive choice in women with HIV-1 infectionS V Thackway, V Furner, A Mijch, et al.

Lancet (London, England)|July 25, 2006

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial, P Yeni, D A Cooper, et al.

Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

International Journal of STD & AIDS|December 18, 2003

Randomized trial of an adherence programme for clients with HIVC K Fairley, R Levy, C R Rayner, et al.

AIDS (London, England)|August 16, 2001

Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugsA L Dunne, F M Mitchell, S K Coberly, et al.

HIV Medicine|January 31, 2009

Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutationsJ Audsley, N Arrifin, L K W Yuen, et al.

AIDS (London, England)|April 1, 1997

Fertility and reproductive choice in women with HIV-1 infectionS V Thackway, V Furner, A Mijch, et al.

Lancet (London, England)|July 25, 2006

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial, P Yeni, D A Cooper, et al.

Pageof 4